Published in J Med Microbiol on May 01, 2009
Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One (2011) 1.88
Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 1.63
Characterization of the fecal microbiome from non-human wild primates reveals species specific microbial communities. PLoS One (2010) 1.49
Microbial ecology and host-microbiota interactions during early life stages. Gut Microbes (2012) 1.12
Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis (2015) 1.09
The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon. PLoS One (2012) 0.89
Impact of genomics on the field of probiotic research: historical perspectives to modern paradigms. Antonie Van Leeuwenhoek (2014) 0.82
Influence of a probiotic mixture on antibiotic induced microbiota disturbances. World J Gastroenterol (2014) 0.78
Probiotics and microbiota composition. BMC Med (2016) 0.78
Prescribing an antibiotic? Do not forget the probiotic. Gastroenterology (2009) 0.75
Unraveling the Differences between Gram-Positive and Gram-Negative Probiotics in Modulating Protective Immunity to Enteric Infections. Front Immunol (2017) 0.75
Dietary perturbations alter the ecological significance of ingested Lactobacillus plantarum in the digestive tract. Sci Rep (2017) 0.75
A nomenclature for restriction enzymes, DNA methyltransferases, homing endonucleases and their genes. Nucleic Acids Res (2003) 7.56
Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med (2004) 6.77
Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proc Natl Acad Sci U S A (2005) 4.46
Experimental factors affecting PCR-based estimates of microbial species richness and evenness. ISME J (2010) 4.15
A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology (2013) 4.06
Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology (2011) 3.84
Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat Rev Microbiol (2008) 3.25
Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A (2011) 3.19
Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88
Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet (2002) 2.74
S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A (2008) 2.65
Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A (2005) 2.35
Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM. Appl Environ Microbiol (2005) 2.24
GAMOLA: a new local solution for sequence annotation and analyzing draft and finished prokaryotic genomes. OMICS (2003) 2.20
Comparison of the complete genome sequences of Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04. J Bacteriol (2009) 2.15
Engineered bacteriophage-defence systems in bioprocessing. Nat Rev Microbiol (2006) 2.10
Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol (2007) 1.91
Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol (2011) 1.88
New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol (2003) 1.88
Variation between observed and true Terminal Restriction Fragment length is dependent on true TRF length and purine content. J Microbiol Methods (2003) 1.85
LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol (2010) 1.85
Functional and comparative genomic analyses of an operon involved in fructooligosaccharide utilization by Lactobacillus acidophilus. Proc Natl Acad Sci U S A (2003) 1.84
Removal of PCR inhibitors from soil DNA by chemical flocculation. J Microbiol Methods (2003) 1.68
Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One (2012) 1.66
Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes. Cancer Biol Ther (2006) 1.63
Characterization of a novel bile-inducible operon encoding a two-component regulatory system in Lactobacillus acidophilus. J Bacteriol (2007) 1.58
Complete genomic sequence of bacteriophage B3, a Mu-like phage of Pseudomonas aeruginosa. J Bacteriol (2004) 1.55
PathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. BMC Genomics (2005) 1.55
Global analysis of carbohydrate utilization by Lactobacillus acidophilus using cDNA microarrays. Proc Natl Acad Sci U S A (2006) 1.50
Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol (2005) 1.50
Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol (2006) 1.42
Microarray analysis of a two-component regulatory system involved in acid resistance and proteolytic activity in Lactobacillus acidophilus. Appl Environ Microbiol (2005) 1.41
Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS One (2012) 1.41
Development and application of a upp-based counterselective gene replacement system for the study of the S-layer protein SlpX of Lactobacillus acidophilus NCFM. Appl Environ Microbiol (2009) 1.40
Identification and inactivation of genetic loci involved with Lactobacillus acidophilus acid tolerance. Appl Environ Microbiol (2004) 1.40
The genomics of lactic acid bacteria. Trends Microbiol (2007) 1.40
Genetic markers unique to Listeria monocytogenes serotype 4b differentiate epidemic clone II (hot dog outbreak strains) from other lineages. Appl Environ Microbiol (2004) 1.38
Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A (2012) 1.30
Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. Appl Environ Microbiol (2008) 1.29
Comparative genomics and transcriptional analysis of prophages identified in the genomes of Lactobacillus gasseri, Lactobacillus salivarius, and Lactobacillus casei. Appl Environ Microbiol (2006) 1.28
Analysis, characterization, and loci of the tuf genes in lactobacillus and bifidobacterium species and their direct application for species identification. Appl Environ Microbiol (2003) 1.28
Expression of antisense RNA targeted against Streptococcus thermophilus bacteriophages. Appl Environ Microbiol (2002) 1.27
Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J Pediatr Gastroenterol Nutr (2009) 1.22
Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ (2013) 1.18
Abortive phage resistance mechanism AbiZ speeds the lysis clock to cause premature lysis of phage-infected Lactococcus lactis. J Bacteriol (2006) 1.14
Epidemic clone I-specific genetic markers in strains of Listeria monocytogenes serotype 4b from foods. Appl Environ Microbiol (2004) 1.14
Functional roles of aggregation-promoting-like factor in stress tolerance and adherence of Lactobacillus acidophilus NCFM. Appl Environ Microbiol (2010) 1.11
Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr (2002) 1.11
Bacterial succession in a petroleum land treatment unit. Appl Environ Microbiol (2004) 1.09
Probiotics and prebiotics in dietetics practice. J Am Diet Assoc (2008) 1.08
Probiotics for recurrent Clostridium difficile disease. J Med Microbiol (2005) 1.06
Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases. Am J Gastroenterol (2013) 1.05
Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev Vaccines (2008) 1.05
Characterization of six Leuconostoc fallax bacteriophages isolated from an industrial sauerkraut fermentation. Appl Environ Microbiol (2002) 1.04
Construction of vectors for inducible and constitutive gene expression in Lactobacillus. Microb Biotechnol (2010) 1.04
Role of transporter proteins in bile tolerance of Lactobacillus acidophilus. Appl Environ Microbiol (2009) 1.04
Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health. FEMS Microbiol Rev (2013) 1.03
Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci (2013) 1.01
Transcriptional and functional analysis of oxalyl-coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes from Lactobacillus acidophilus. Appl Environ Microbiol (2006) 0.99
Characterization of the tre locus and analysis of trehalose cryoprotection in Lactobacillus acidophilus NCFM. Appl Environ Microbiol (2006) 0.99
Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort. Inflamm Bowel Dis (2015) 0.99
Functional and phenotypic characterization of a protein from Lactobacillus acidophilus involved in cell morphology, stress tolerance and adherence to intestinal cells. Microbiology (2010) 0.98
Genome sequence and characteristics of Lrm1, a prophage from industrial Lactobacillus rhamnosus strain M1. Appl Environ Microbiol (2008) 0.98
Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease. Gut (2011) 0.97
Genetic analysis of two bile salt hydrolase activities in Lactobacillus acidophilus NCFM. Appl Environ Microbiol (2005) 0.97
Identification and phenotypic characterization of the cell-division protein CdpA. Gene (2004) 0.97
Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc Natl Acad Sci U S A (2013) 0.97
Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol Ecol (2006) 0.96
A rendezvous with our microbes. Proc Natl Acad Sci U S A (2011) 0.95
Dissimilar properties of two recombinant Lactobacillus acidophilus strains displaying Salmonella FliC with different anchoring motifs. Appl Environ Microbiol (2011) 0.95
Inflammatory bowel disease and environmental influences. Gastroenterol Clin North Am (2002) 0.95
Bacteriophage defense systems and strategies for lactic acid bacteria. Adv Appl Microbiol (2004) 0.95
Identification and characterization of Leuconostoc fallax strains isolated from an industrial sauerkraut fermentation. Appl Environ Microbiol (2002) 0.94
Assessment of Lactobacillus gasseri as a candidate oral vaccine vector. Clin Vaccine Immunol (2011) 0.94
Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine. Future Microbiol (2010) 0.94
Transcriptional and functional analysis of galactooligosaccharide uptake by lacS in Lactobacillus acidophilus. Proc Natl Acad Sci U S A (2011) 0.94
Expression of a heterologous manganese superoxide dismutase gene in intestinal lactobacilli provides protection against hydrogen peroxide toxicity. Appl Environ Microbiol (2004) 0.94
Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis. Inflamm Bowel Dis (2013) 0.93
Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm Bowel Dis (2010) 0.92
Marijuana use patterns among patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.92
Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. Inflamm Bowel Dis (2013) 0.92
Genomic evolution of domesticated microorganisms. Annu Rev Food Sci Technol (2010) 0.91
Marker-free chromosomal integration of the manganese superoxide dismutase gene (sodA) from Streptococcus thermophilus into Lactobacillus gasseri. FEMS Microbiol Lett (2005) 0.90
Directed chromosomal integration and expression of the reporter gene gusA3 in Lactobacillus acidophilus NCFM. Appl Environ Microbiol (2011) 0.90
Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent. Inflamm Bowel Dis (2011) 0.89
Genomic features of Lactobacillus species. Front Biosci (Landmark Ed) (2009) 0.88
Transcriptional analysis of prebiotic uptake and catabolism by Lactobacillus acidophilus NCFM. PLoS One (2012) 0.87
Specific Lactobacillus species differentially activate Toll-like receptors and downstream signals in dendritic cells. Expert Rev Vaccines (2008) 0.86
Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis. Dig Dis Sci (2011) 0.86
Growth factors as treatment options for intestinal inflammation. Ann N Y Acad Sci (2006) 0.86
Barriers to enrollment in inflammatory bowel disease randomized controlled trials: an investigation of patient perspectives. Inflamm Bowel Dis (2012) 0.85
Antisense RNA targeting of primase interferes with bacteriophage replication in Streptococcus thermophilus. Appl Environ Microbiol (2004) 0.85
Validation of interactive voice response system administration of the Short Inflammatory Bowel Disease Questionnaire. Inflamm Bowel Dis (2009) 0.85
A functional glycogen biosynthesis pathway in Lactobacillus acidophilus: expression and analysis of the glg operon. Mol Microbiol (2013) 0.85
Insights into glycogen metabolism in Lactobacillus acidophilus: impact on carbohydrate metabolism, stress tolerance and gut retention. Microb Cell Fact (2014) 0.85
Lactococcus lactis lytic bacteriophages of the P335 group are inhibited by overexpression of a truncated CI repressor. J Bacteriol (2002) 0.84